Evidence map›Paper›PMID 24194626›Full record

ReviewActa histochemica et cytochemica2013

Clinicopathological and molecular histochemical review of skull base metastasis from differentiated thyroid carcinoma.

Akira Matsuno, Mineko Murakami, Katsumi Hoya, Shoko M Yamada, Shinya Miyamoto, So Yamada, Jae-Hyun Son, Hajime Nishido, Fuyuaki Ide, Hiroshi Nagashima and 10 more

Open access · diamondAbstract readReview
In one paragraph

Review in Acta histochemica et cytochemica, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Pituitary Metastasis of Thyroid Carcinoma: A Case Report.The American journal of case reports · 2018
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Skull metastasis from follicular thyroid carcinoma: report of three cases and review of literature.International journal of clinical and experimental pathology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 1 country.

Akira MatsunoDepartment of Neurosurgery, Teikyo University Chiba Medical Center, 3426-3 Anesaki, Ichihara City, Chiba 299-0111, Japan.
Mineko Murakami
Katsumi Hoya
Shoko M Yamada
Shinya Miyamoto
So Yamada
Jae-Hyun Son
Hajime Nishido
Fuyuaki Ide
Hiroshi Nagashima
Mutsumi Sugaya
Toshio Hirohata
Akiko Mizutani
Hiroko Okinaga
Yudo Ishii
Shigeyuki Tahara
Akira Teramoto
R Yoshiyuki Osamura
Kazuto Yamazaki
Yasuo Ishida
Teikyo University Chiba Medical Center · JPNippon Medical School · JPMita Hospital · JPTeikyo Heisei University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skull base metastasis from differentiated thyroid carcinoma including follicular thyroid carcinoma (FTC) and papillary thyroid carcinoma (PTC) is a rare clinical entity. Eighteen FTC cases and 10 PTC cases showing skull base metastasis have been reported. The most common symptom of skull base metastasis from FTC and PTC is cranial nerve dysfunction. Bone destruction and local invasion to the surrounding soft tissues are common on radiological imaging. Skull base metastases can be the initial clinical presentation of FTC and PTC in the presence of silent primary sites. The possibility of skull base metastasis from FTC and PTC should be considered in patients with the clinical symptoms of cranial nerve dysfunction and radiological findings of bone destruction. A variety of genetic alterations in thyroid tumors have been identified to have a fundamental role in their tumorigenesis. Molecular histochemical studies are useful for elucidating the histopathological features of thyroid carcinoma. Recent molecular findings may provide novel molecular-based treatment strategies for thyroid carcinoma.

Indexed as

follicular thyroid carcinomaiodine-131 brachytherapypapillary thyroid carcinomaskull base metastasisthyroid-stimulating hormone suppression

Identifiers

PMID24194626
PMCPMC3813819
OpenAlexW2077110313

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.